Mark Hamner to Adrenergic alpha-2 Receptor Antagonists
This is a "connection" page, showing publications Mark Hamner has written about Adrenergic alpha-2 Receptor Antagonists.
Connection Strength
0.579
-
Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn Behav Ther. 2018 09; 47(5):351-371.
Score: 0.579
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.